News | April 30, 2007

AngioDynamics Brings Peripheral PTA Catheter to U.S.

May 1, 2007 — AngioDynamics Inc. announced today the introduction of its Profiler Balloon Dilatation Catheter in the U.S. market. The new low profile balloon catheter is indicated for general percutaneous transluminal angioplasty (PTA) of the iliac, femoral, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

"The development of low profile PTA balloon technology allows physicians to perform angioplasty in a less invasive manner, which improves the overall quality of patient care," said Dr. John Aruny, associate professor and co-chief, Vascular and Interventional Radiology at Yale University School of Medicine. "This device, with its low profile configuration, is an excellent example of a new technology that limits the size of the introducer sheath to 5F while allowing inflation diameters up to 8mm. The ability to work through smaller sheaths will directly contribute to lessening puncture site morbidity," he added.

AngioDynamics' Profiler offers a broad range of low profile PTA balloons, with configurations of up to 8mm x 4cm balloons compatible with 5F sheaths, which provide access to small vessels, tortuous anatomy, and tight stenotic lesions. Additionally, the Profiler family offers a line of 9mm and 10mm balloons that are compatible with a 6F sheath.

For more information visit www.angiodynamics.com

Related Content

News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
The LimFlow Percutaneous Deep Vein Arterialization System (pDVA) converts veins into arteries to restore blood flow in critical limb ischemia (CLI).

The LimFlow Percutaneous Deep Vein Arterialization System (pDVA) converts veins into arteries to restore blood flow in critical limb ischemia (CLI). This image shows how the covered stents used with the system connect to create a new arterial pathway.

News | Peripheral Artery Disease (PAD)| August 02, 2017
Aug.
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial
News | Stents Peripheral| July 26, 2017
Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK)...
Sponsored Content | Videos | Peripheral Artery Disease (PAD)| July 25, 2017
This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross,
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Artery Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
Overlay Init